Johnson & Johnson
USUSDJohnson & Johnson (MX:JNJ) — Biotechnology: Pharmaceutical Preparations. Numărul de burse pe care se tranzacționează acțiunile companiei: 3. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
Despre Companie
- Site Web
- jnj.com
- Relații cu Investitorii
- investor.jnj.com/overview/default.aspx
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sediu Central
- New Brunswick, United States
- Director General
- Joaquin Duato
- Angajați
- 136 400
- Fondată
- 1886
- Listată din
- 29.05.2003 (MX:JNJ)
- Acțiuni în Circulație
- Free Float
- 2.41 mld.
- Capitalizare de Piață
- 655.37 mld. USD
- Insideri
- 0.05%
- Investitori Instituționali
- 76.73%
- Industrie (SIC)
- Pharmaceutical Preparations
- Formă Juridică
- XSNP
- ISIN
- US4781601046
- LEI
- 549300G0CFPGEF6X2043
- P/E
- 40.6
- Rata de Distribuire
- 60.0%
- FCF
- 22.2 mld. USD
- Plăți / FCF
- 57%
- Datorie
- 49.0 mld. USD1.3 ani FCF
- Vechimea Dividendelor
- 56+ ani
- Câștiguri, FCF și dividende plătite — pentru cele 12 luni până la 28.06.2026 (cel mai recent raport al companiei).
- NAV
Descriere
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dividende
Johnson & Johnson (JNJ) plătește dividende trimestrial. Pe an (12 luni până la și inclusiv cea mai recentă plată anunțată): 5.32 USD pe acțiune (plăți: 4). Aceasta reprezintă aproximativ 2.08% din prețul actual al acțiunilor. Următoarea dată ex-dividend este 24.11.2026: 1.34 USD pe acțiune, plătită la 08.12.2026. Istoric neîntrerupt al dividendelor: 56 ani.
| Data Ex | Plată | Sumă | % | Tip | Simbol |
|---|---|---|---|---|---|
| 2026-11-24 anunțat | 2026-12-08 | 1.3400 USD | 0.5/2.1 % | trimestrial | US:JNJ |
| 2026-08-25 | 2026-09-08 | 1.3400 USD | 0.5/1.9 % | trimestrial | US:JNJ |
| 2026-05-26 | 2026-06-09 | 1.3400 USD | 0.6/2.2 % | trimestrial | US:JNJ |
| 2026-02-24 | 2026-03-10 | 1.3000 USD | 0.5/2.1 % | trimestrial | US:JNJ |
| 2025-11-25 | 2025-12-09 | 1.3000 USD | 0.6/2.5 % | trimestrial | US:JNJ |
| 2025-08-26 | 2025-09-09 | 1.3000 USD | 0.7/2.8 % | trimestrial | US:JNJ |
| 2025-05-27 | 2025-06-10 | 1.3000 USD | 0.9/3.3 % | trimestrial | US:JNJ |
| 2025-02-18 | 2025-03-04 | 1.2400 USD | 0.8/3.2 % | trimestrial | US:JNJ |
| 2024-11-26 | 2024-12-10 | 1.2400 USD | 0.8/3.2 % | trimestrial | US:JNJ |
| 2024-08-27 | 2024-09-10 | 1.2400 USD | 0.5/1.9 % | trimestrial | US:JNJ |
| 2024-05-20 | 2024-06-04 | 1.2400 USD | 0.5/1.9 % | trimestrial | US:JNJ |
| 2024-02-16 | 2024-03-05 | 1.1900 USD | 0.5/1.9 % | trimestrial | US:JNJ |
| 2023-11-20 | 2023-12-05 | 1.1900 USD | 0.5/1.8 % | trimestrial | US:JNJ |
| 2023-08-25 | 2023-09-07 | 1.1900 USD | 0.5/1.8 % | trimestrial | US:JNJ |
| 2023-05-22 | 2023-06-06 | 1.1900 USD | 0.5/1.8 % | trimestrial | US:JNJ |
| 2023-02-17 | 2023-03-07 | 1.1300 USD | 0.4/1.8 % | trimestrial | US:JNJ |
| 2022-11-21 | 2022-12-06 | 1.1300 USD | 0.4/1.7 % | trimestrial | US:JNJ |
| 2022-08-22 | 2022-09-06 | 1.1300 USD | 0.4/1.7 % | trimestrial | US:JNJ |
| 2022-05-23 | 2022-06-07 | 1.1300 USD | 0.4/1.3 % | trimestrial | US:JNJ |
| 2022-02-18 | 2022-03-08 | 1.0600 USD | 0.4/0.8 % | trimestrial | US:JNJ |
| 2021-11-22 | 2021-12-07 | 1.0600 USD | 0.4/0.4 % | trimestrial | US:JNJ |
Știri din Această Săptămână
Comunicate de presă de pe site-ul investitorilor companiei, actualizate zilnic. Linkurile duc către site-ul companiei. Titlurile sunt în limba originală, ca pe site-ul companiei.
Cei Mai Mari Acționari
| Deținător | Participație | Acțiuni | Data Raportului |
|---|---|---|---|
| BlackRock | 8.8% | 212.1 mil. | 2026-06-30 |
| Vanguard Capital Managem… | 6.52% | 157.23 mil. | 2026-06-30 |
| State Street Corporation | 5.55% | 133.78 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.17% | 76.42 mil. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.67% | 64.37 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 62.38 mil. | 2026-06-30 |
| Geode Capital Management… | 2.45% | 59.09 mil. | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.42% | 58.3 mil. | 2026-06-30 |
| Morgan Stanley | 1.86% | 44.81 mil. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 32.48 mil. | 2026-07-31 |
| NORGES BANK | 1.32% | 31.83 mil. | 2026-06-30 |
| State Farm Mutual Automo… | 1.31% | 31.59 mil. | 2026-06-30 |
| Fidelity Concord Street… | 1.29% | 31.13 mil. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 29.45 mil. | 2026-08-31 |
| Northern Trust Corporati… | 1.19% | 28.79 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 22.91 mil. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.3 mil. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 13.53 mil. | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 13.07 mil. | 2026-06-30 |
| VANGUARD WHITEHALL FUNDS… | 0.39% | 9.48 mil. | 2026-04-30 |
| DUATO JOAQUIN BOIX (Chie… | ≈0.01% | 307 837 | 2026-08-13 |
| TAUBERT JENNIFER L (Offi… | ≈0.01% | 194 451 | 2026-08-17 |
| WENGEL KATHRYN E (Chief… | ≈0% | 114 659 | 2026-06-11 |
| WOLK JOSEPH J (Chief Fin… | ≈0% | 85 008 | 2026-02-17 |
| SCHMID TIMOTHY (Officer) | ≈0% | 26 251 | 2026-09-02 |
| SWANSON JAMES D (Chief T… | ≈0% | 25 698 | 2026-02-17 |
| REED JOHN C (Officer) | ≈0% | 24 911 | 2026-05-01 |
| DECKER ROBERT J (Officer… | ≈0% | 24 462 | 2026-02-27 |
| BROADHURST VANESSA (Offi… | ≈0% | 23 003 | 2026-07-20 |
| MULHOLLAND KRISTEN (Offi… | ≈0% | 19 830 | 2026-02-13 |
| The Vanguard Group | — | — | — |
